Caspofungin use in daily clinical practice for treatment of invasive aspergillosis: Results of a Prospective Observational Registry

A prospective observational registry assessed real world experience with caspofungin monotherapy or combination therapy for the initial or salvage treatment of proven or probable invasive aspergillosis (IA).

Saved in:

Bibliographic Details
Main Authors:	Maertens, Johan (Author) , Egerer, Gerlinde (Author) , Shin, Wan Shik (Author) , Reichert, Dietmar (Author) , Stek, Michael (Author) , Chandwani, Sheenu (Author) , Shivaprakash, Malathi (Author) , Viscoli, Claudio (Author)
Format:	Article (Journal)
Language:	English
Published:	22 June 2010
In:	BMC infectious diseases Year: 2010, Volume: 10, Pages: 1-7
ISSN:	1471-2334
DOI:	10.1186/1471-2334-10-182
Online Access:	Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1186/1471-2334-10-182 Verlag, lizenzpflichtig, Volltext: https://bmcinfectdis.biomedcentral.com/articles/10.1186/1471-2334-10-182
Author Notes:	Johan Maertens, Gerlinde Egerer, Wan Shik Shin, Dietmar Reichert, Michael Stek, Sheenu Chandwani, Malathi Shivaprakash, Claudio Viscoli, the study team CAN-DO(IA)

Description
Summary:	A prospective observational registry assessed real world experience with caspofungin monotherapy or combination therapy for the initial or salvage treatment of proven or probable invasive aspergillosis (IA).
Item Description:	Gesehen am 25.04.2023
Physical Description:	Online Resource
ISSN:	1471-2334
DOI:	10.1186/1471-2334-10-182